Dataset Information


Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus.



The treatment of patent ductus arteriosus (PDA) in very low birth weight (VLBW) infants remains a challenge. The ability to predict which infants will respond to indomethacin could spare some from the risks of unnecessary medications. Our objective was to determine if indicators of acid-base homeostasis could predict response to indomethacin treatment for ductal closure, and thus help guide treatment decisions.


We performed a retrospective analysis of medical records of VLBW (ResultsOf the 91 infants included in the study, 62 (68%) responded to the first course of indomethacin with successful ductal closure. Multivariable regression modeling revealed that both base excess and hematocrit were independently associated with indomethacin response; odds of PDA closure increased with increasing base excess (OR [odds ratio]: 1.81; 95% confidence interval [CI]: 1.36-2.60) and increasing hematocrit (OR: 1.21; 95% CI: 1.01-1.45). The optimal cutoff value for base excess was -?4.56, with a sensitivity of 96.8% (95% CI: 89-100) and specificity of 79.3% (95% CI: 60-92); optimal cutoff value for hematocrit was 40, with 69.4% sensitivity (95% CI: 56-80) and 65.5% specificity (95% CI: 46-82).


Base excess and hematocrit may be independent predictors of indomethacin response in VLBW infants with PDA. Low-cost and readily accessible, acid-base indicators such as base excess could help guide treatment decisions.

PROVIDER: S-EPMC6704716 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC8095061 | BioStudies
| S-EPMC5654678 | BioStudies
| S-EPMC5645220 | BioStudies
| S-EPMC8631614 | BioStudies
2018-01-01 | S-EPMC5885871 | BioStudies
| S-EPMC7877482 | BioStudies
| S-EPMC7023762 | BioStudies
| S-EPMC6817966 | BioStudies
| S-EPMC6561645 | BioStudies
| S-EPMC7478603 | BioStudies